Alzheimer’s Drugs Debate Grows Over £90K Cost
A fresh analysis is raising concerns about whether recently developed Alzheimer’s treatments deliver meaningful benefits for patients, despite earlier optimism surrounding their arrival. The findings suggest that while the drugs represent scientific progress, their real world impact may fall short of expectations. New analysis questions whether widely discussed treatments meaningfully improve patients lives. The treatments, […]
Understanding the link between anxiety and Parkinson’s disease in adults over 50
Recent research highlights a concerning connection between anxiety and an increased risk of Parkinson’s disease (PD) in individuals over the age of 50. This finding emphasizes the importance of early detection and proactive health care to mitigate the progression of PD. Key findings from the study Individuals who develop anxiety after 50 may face a […]